Levoleucovorin
Advanced/Metastatic Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLCPhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Advanced/Metastatic Gastroesophageal Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Epirubicin Diwakar Davar | Phase 3 | BBB |
Calcium folinate pentahydrate Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
LENVATINIB Merck Sharp & Dohme LLC | Phase 3 | B |
Same molecule, other indications
Levoleucovorin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →